A pharmacodynamic study with ticagrelor in Hispanic patients

Study identifier:D5130L00012

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor versus Clopidogrel in Hispanic Patients with Stable Coronary Artery Disease

Medical condition

Stable coronary artery disease

Phase

Phase 4

Healthy volunteers

No

Study drug

Ticagrelor, Clopidogrel

Sex

All

Actual Enrollment

53

Study type

Interventional

Age

18 Years - 150 Years

Date

Study Start Date: 01 Apr 2012
Primary Completion Date: 01 May 2013
Study Completion Date: 01 May 2013

Study design

Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Jul 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria